Siegfried Kasper, MD
- 20Articles
- 116.7KReads
- 1997–2020Active
- 118Collaborators
- 709Citations
About
Siegfried Kasper, MD, has published extensively on mood disorders, including major depressive disorder, bipolar disorder, and treatment-resistant depression, with a focus on pharmacologic treatments and clinical predictors of treatment response. His work encompasses studies on novel antidepressants, such as esketamine and agomelatine, as well as investigations into anxiety disorders, schizophrenia, and suicide risk factors. Kasper's research also addresses neuropsychiatric aspects of circadian rhythms and machine learning applications in predicting treatment outcomes. His publications span from 1997 to 2020 in peer-reviewed psychiatric journals.
Publications
Psychotic Features in Patients With MDD
January 15, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
